Pharmaceuticals & consumables
Bayer’s Eylea 8mg injection added to PBS
Eylea 8mg, a higher dose of aflibercept, is now approved in Australia and is being added to the Pharmaceutical Benefits...
Read more
Gov adds drug for disease that can impact eyes to PBS roster
Australians with Fabry disease, a rare genetic condition that can lead to alterations in the eye and life-threatening complications, now...
Read more
Establishing a stable tearfilm for predicable results
Identifying and addressing dry eye disease is one of the most important steps before anterior segment surgery. DR AVENELL CHEW...
Read more
Cold weather means drier eyes
Although modern-day lifestyles and working environments play a critical role in how we use and rely on our eyes, eye...
Read more
Bausch + Lomb launching dry eye nutritional supplement after favourable study
Global ophthalmic company Bausch + Lomb (B+L) has achieved statistically significant results from a trial evaluating the efficacy and safety...
Read more
Considerations for low-dose atropine for myopia control in a non-Asian population
At the completion of this article, the reader should be able to improve the application of atropine in myopia management,...
Read moreWhat is the ideal concentration of atropine for myopia control?
At the completion of this article, the reader should be able to improve their management of progressive myopia with atropine,...
Read more
Dry eye disease and co-morbidities
At the completion of this article, the reader will be able to improve their management of dry eye disease...
Read more
Apellis issues safety update after rare real-world retinal vasculitis reports
An investigation into rare events of retinal vasculitis linked to Apellis Pharmaceutical’s new therapy, SYFOVRE, for geographic atrophy (GA) has...
Read more
FDA warning to companies marketing unapproved ophthalmic drug products
The US Food and Drug Administration (FDA) issued warning letters to eight firms marketing unapproved ophthalmic drug products. These warnings...
Read more